Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06545669Phase 4Completed
Phase 4, randomised, open-label trial in tobacco dependence (2 arms), sponsored by Johns Hopkins University. Primary endpoints: Acceptability and Feasibility as assessed by number of barriers at 6 months, Acceptability and Feasibility as assessed by completion of modules at 6 months and 1 more. Started Oct 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06545669.